Cardiology journal
ORItavancin as a therapeutic regimen for Cardiac Implantable Electronic Devices infections with multidrug-resistant Gram-positive cocci (ORI-4-CIEDi) pilot study: rationale and design.
Danuta Łoboda, Denis Swolana, Michał Joniec, Sylwia Gładysz-Wańha, Michał Gibiński, Karolina Simionescu, Eugeniusz Piłat, Krzysztof S Gołba, Robert D Wojtyczka, Sławomir Wilczyński, Beata Sarecka-Hujar
Published: 202510.5603/cj.107098
No abstract available for this study.